any type of epithelial lung cancer other than small-cell lung carcinoma
Researchers discover new therapeutic target for non-small cell lung cancer: Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases ...
medicalxpress.com/news/2024-04-therapeutic-small-cell-lung-cancer.html
Genomic deletions explain why some types of melanoma resist targeted therapies: Melanoma is the deadliest form of skin cancer. With global incidence rates rising ...
medicalxpress.com/news/2024-04-genomic-deletions-melanoma-resist-therapies.html
Study suggests liquid biopsy could detect and monitor aggressive small-cell lung cancer
medicalxpress.com/news/2024-04-liquid-biopsy-aggressive-small-cell.html
Golfers are paying closer attention to sun risk, skin cancer: Golfers are in the sun as much if not more than players in other sports. It can be as many as eight ...
apnews.com/article/golf-skin-cancer-sunscreen-villegas-cink-fddd508cca48b1de4622e70158d33225
Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results
seekingalpha.com/article/4682837-iovance-biotherapeutics-riding-the-favorable-moment-could-bring-excellent-results
Paid articlePaid
In The Headlines: New Data on Targeted Systemic Treatment for Early-Stage Resectable NSCLC
twitter.com/i/broadcasts/1ZkKzjyorzXKv
Continued Benefit, More Toxicity With First-Line Osimertinib Plus Chemo in NCSLC: Patients with advanced EGFR-mutated NSCLC who were given osimertinib plus ...
medscape.com/viewarticle/continued-benefit-more-toxicity-first-line-osimertinib-plus-2024a10005n1
Novocure's device shown to slow cancer progression in the brain in trial: Novocure's therapy met the main goal of a late-stage trial of slowing the progression ...
reuters.com/business/healthcare-pharmaceuticals/novocures-lung-cancer-therapy-succeeds-late-stage-trial-2024-03-27/
Join us for a live conversation as we explore new data on targeted therapies for early-stage, resectable NSCLC! This lively discussion will feature Drs Ibiayi ... Show more
📌 NEXT WEEK on March 27! Join this lively conversation to review the latest therapeutic strategies in early-stage NSCLC. Free CME credit available!
👉 Save ... Show more www.facebook.com/events/421258333756121
Osimertinib Plus Chemo Approved for EGFR-mutated NSCLC: With the new approval, patients now have the option of combination treatment or osimertinib monotherapy.
medscape.com/viewarticle/osimertinib-plus-chemo-approved-egfr-mutated-nsclc-2024a10003j5
Paid articlePaid AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial: AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival ...
reuters.com/business/healthcare-pharmaceuticals/astrazenecas-imfinzi-shows-promise-treating-aggressive-lung-cancer-2024-04-05/
Quick Glance: AstraZeneca's Imfinzi Shows Promise in Treating Aggressive Lung Cancer
- AstraZeneca announced that their cancer drug Imfinzi helps improve overall and progression-free survival in patients with limited-stage small cell lung cancer.
- In a late-stage trial, the drug demonstrated a statistically significant and clinically meaningful improvement in the dual primary goals of overall survival and progression-free survival.
- Small cell lung cancer is recognized for its high level of aggressiveness and rapid disease progression despite initial treatment with chemotherapy and radiotherapy.
- Imfinzi is part of the Anglo-Swedish drugmaker's key cancer portfolio and accounted for 23% of total group revenue last year.
MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024: Read about MacroGenics' positive safety update from phase 2 TAMARACK study ...
seekingalpha.com/article/4682276-macrogenics-positive-safety-update-leads-to-two-major-inflection-points-in-2024
Paid articlePaid
Bristol Myers Squibb to lay off hundreds of workers following its $4.8B merger with this San Diego biotech
sandiegouniontribune.com/business/story/2024-04-03/bristol-myers-squibb-to-lay-off-hundreds-of-workers-following-its-4-8b-merger-with-this-san-diego-biotech
Is Consolidation Osimertinib Superior to Durvalumab in EGFR-Mutated Non–Small Cell Lung Cancer?
medscape.com/viewarticle/consolidation-osimertinib-superior-durvalumab-egfr-mutated-2024a10002qs
Paid articlePaid In the Headlines: New Data on Targeted Systemic Treatment for Early-Stage Resectable NSCLC
medscape.org/viewarticle/1000383
Blood test detects Stage 4 lung cancer for Kat Robinson: A woman from Dorset was alerted to her stage 4 lung cancer following her involvement in a blood test ...
bournemouthecho.co.uk/news/24204962.blood-test-detects-stage-4-lung-cancer-kat-robinson/
Merck combination treatment for lung cancer fails late-stage study: Merck said on Thursday a combination of two of its cancer drugs failed to meet the main goals ...
reuters.com/business/healthcare-pharmaceuticals/merck-combination-treatment-lung-cancer-fails-late-stage-study-2024-03-21/
Health Benefits of Rhodiola: Rhodiola offers many health benefits when incorporated into a balanced lifestyle. Learn about how the herb can support mental and ...
health.com/rhodiola-benefits-8606881
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
cnbc.com/2024/03/10/pfizer-is-betting-big-on-cancer-drugs-after-covid-decline.html
FDA approves J&J's combination therapy for a type of lung cancer: The U.S. health regulator on Friday approved Johnson & Johnson's therapy in combination with ...
reuters.com/business/healthcare-pharmaceuticals/fda-approves-jnjs-combination-therapy-patients-with-type-lung-cancer-2024-03-01/
Study proposes streamlined approach to developing cancer drugs: Drug discovery can be a frustrating process of trial and error. Scientists using fragment-based ...
medicalxpress.com/news/2024-02-approach-cancer-drugs.html
129 people arrested in Pharmacy Boards crackdown on illegal pharmaceuticals: The operation is aimed at enforcing regulatory standards, ensuring public safety ...
standardmedia.co.ke/health/health-science/article/2001490289/129-people-arrested-in-pharmacy-boards-crackdown-on-illegal-pharmaceuticals
RBI gives 15 days extension to Paytm Bank customers: According to reports, PPB has around 40 million merchants on its platform. The payments bank has around 350 ...
financialexpress.com/business/banking-finance-rbi-gives-15-more-days-till-march-15-to-paytm-payments-bank-to-stop-transactions-3396650/
In today’s (very) brief headlines... House sales surge, and can an AstraZeneca drug slow disease progression? 🩻
1. Buyer interest is on the rise once more ... Show more www.cityam.com/house-sales-surge-as-green-shoots-emerge-in-property-market/ www.cityam.com/astrazeneca-tagrisso-drug-shows-highly-impactful-results-in-lung-cancer-trial/ www.cityam.com/inside-bafta-2024-how-awards-ceremony-takes-over-london/ #houseprices #housesales #housingcrisis #astrazeneca #lungcancer #cancertrial #cancerdrug #baftas #openheimer #christophernolan #cillianmurphy #entertainmnetnews #businessnews #economy #cityamnews
Betfair | Online Sportwetten & Wettquoten: Fußballwetten & Live Wetten: Online wetten mit Betfair Sportwetten. Die besten Bundesliga-Quoten. Livewetten und ...
betfair.com/de
Paytm Bank didn’t comply on multiple parameters: Das: The decision to impose restrictions on PPB was persistent non-compliance with regulatory norms and lack of ...
financialexpress.com/business/banking-finance-paytm-bank-didnt-comply-on-multiple-parameters-das-3388620/
My father got lung cancer without a puff of smoke: Eliud Kibiwott, 68, didn’t drink or smoke yet he was diagnosed with lung cancer.
nation.africa/kenya/health/my-father-got-lung-cancer-without-a-puff-of-smoke-4514592
Immune-Related Adverse Events Linked to Longer Survival in Patients With Non-Small Cell Lung Cancer
medscape.com/viewarticle/immune-related-adverse-events-linked-longer-survival-2024a100023v
Paid articlePaid Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33%: Gilead Sciences (GILD.O) said on Monday it has raised its stake in Arcus Biosciences ...
reuters.com/business/healthcare-pharmaceuticals/gilead-sciences-raises-stake-cancer-centric-arcus-biosciences-33-2024-01-29/
Biomarker Testing Optimizes Therapy Choice in Advanced NSCLC: Patients with advanced NSCLC who received optimal first-line treatment based on biomarker testing ...
medscape.com/viewarticle/biomarker-testing-optimizes-therapy-choice-advanced-nsclc-2024a10001i9
Adaptive SABR Boost Shows Promise in Advanced NSCLC: Radiation dose-escalation combined with stereotactic ablative radiotherapy may improve locoregional control ...
medscape.com/viewarticle/adaptive-sabr-boost-shows-promise-advanced-nsclc-2024a10001ip
Immunotherapy Increasingly Initiated Near Death in Metastatic Cancer: Patients with metastatic cancer are increasingly starting immunotherapy within a month ...
medscape.com/viewarticle/immunotherapy-increasingly-initiated-near-death-metastatic-2024a10001ik
Experiencing the Evolution of Early-Stage Non-Small Cell Lung Cancer Treatment: Jared Weiss, MD, reflects on his first encounter in training with a patient with ...
medscape.com/viewarticle/999477
Paid articlePaid Jamie Chaft, MD, reflects on how her mentor, Dr Mark Kris, shaped her approach to treating early-stage non-small cell lung cancer. #OncTwitter #NSCLC
ms.spr.ly/6012imfS0
Advice to Early-Career Clinicians: Recognize the Complexity of Early-Stage Non-Small Cell Lung Cancer
medscape.com/viewarticle/999492
Paid articlePaid Jared Weiss, MD, examines the need for a variety of measures to understand the total picture of treating early-stage #NSCLC . ms.spr.ly/6015imb79 #MedTwitter
Reducing Disparities in the Treatment of Early Non-Small Cell Lung Cancer: Jared Weiss, MD, considers the many causes and forms of treatment disparities in early ...
medscape.com/viewarticle/999478
Paid articlePaid What Is Squamous Cell Carcinoma (SCC) of the Lung?: Squamous cell carcinoma (SCC) of the lung is a type of non-small cell lung cancer that often develops in the ...
health.com/squamous-cell-lung-carcinoma-8431808
ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes
medscape.org/viewarticle/998606
Beyond Overall Survival: Considering Quality of Life in the Treatment of Early Non-Small Cell Lung Cancer
medscape.com/viewarticle/999479
Paid articlePaid AI in Oncology: Sorting Through Misinformation: David J. Kerr, CBE, MD, DSc, discusses the use of artificial intelligence in oncology now and in the future.
medscape.com/viewarticle/994675
Gilead's Trodelvy fails to meet main goal in lung cancer trial: Gilead Sciences (GILD.O) said on Monday its drug, Trodelvy, failed to significantly improve ...
reuters.com/business/healthcare-pharmaceuticals/gilead-says-trodelvy-fails-meet-primary-goal-2nd-line-lung-cancer-trial-2024-01-22/
How the Microbiome Influences the Success of Cancer Therapy: Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape ...
medscape.com/viewarticle/999042
Early NSCLC: Three Forms That Contribute to Failure to Diagnose: Jared Weiss, MD, reflects on the profound impact of patient experiences in which early diagnosis ...
medscape.com/viewarticle/999476
Paid articlePaid Test your knowledge: Which of the following classes is used in treatment of ROS1-positive non-small cell lung cancer?
Take our activity to learn more ➡️ ms.spr.ly/6185iZgqU
Omega Therapeutics: Starting 2024 With A Bang: Omega Therapeutics is revolutionizing gene expression modification for therapeutic purposes ...
seekingalpha.com/article/4662084-omega-therapeutics-starting-2024-with-a-bang
Paid articlePaid Blueprint Medicines: Looking Toppy: After its two-month nearly 100% surge, now is the time to be taking profits in Blueprint Medicines Corp shares ...
seekingalpha.com/article/4661212-blueprint-medicines-looking-toppy
Paid articlePaid
Not just a smokers' disease: Breaking the lung cancer stigma: Not all forms of lung cancer are caused by smoking. In this Special Feature, we debunk some myths ...
medicalnewstoday.com/articles/things-you-may-not-know-about-egfr-positive-lung-cancer
mRNA skin cancer therapy halves risk of death in clinical trial: Moderna has announced results of a Phase 2b trial of its mRNA treatment for skin cancer ...
newatlas.com/medical/moderna-mrna-skin-cancer-clinical-trial/
US FDA puts clinical hold on Iovance's cancer therapy trial: The U.S. health regulator has placed a clinical hold on Iovance Biotherapeutics' (IOVA ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-places-clinical-hold-iovances-lung-cancer-treatment-trial-2023-12-27/
Cancer-hit mum pays £85k-a-year for treatment not approved in UK: Julie Woodington, 56, says she fell ill with 'the wrong type of cancer'
stokesentinel.co.uk/news/health/cancer-hit-mum-pays-85k-8984303
Evaluating Mirati Therapeutics' CVR Value In The Wake Of The Bristol Myers Acquisition
seekingalpha.com/article/4659531-evaluating-mirati-therapeutics-cvr-value-in-the-wake-of-the-bristol-myers-acquisition
Paid articlePaid Nuvalent: Strong Data, But Properly Valued: Nuvalent is not going to stay out of funds or high valuation if they produce good data, as they have been ...
seekingalpha.com/article/4659450-nuvalent-strong-data-but-properly-valued
Paid articlePaid
'I have to pay £5k every three weeks just to stay alive': Julie has to sit next to other patients who receive the same treatment for free
lancs.live/news/uk-world-news/i-pay-5k-every-three-28314483
Eight main signs of lung cancer after death of Andre Braugher: Andre Braugher stopped smoking in 2014
walesonline.co.uk/news/uk-news/eight-main-signs-lung-cancer-28293893
Sanofi to stop developing experimental lung cancer drug after trial failure: Sanofi will stop developing an experimental lung cancer medicine after it failed to ...
english.alarabiya.net/life-style/healthy-living/2023/12/21/Sanofi-to-stop-developing-an-experimental-lung-cancer-drug-after-trial-failure
Chinese drug hailed as ‘breakthrough therapy’ shows promising results against lung cancer: Report
wionews.com/science/chinese-drug-hailed-as-breakthrough-therapy-shows-promising-results-against-lung-cancer-report-671068
Merus: (Maybe) Building A Better Bispecific: Read about Merus N.V.'s promising drugs targeting head and neck cancer, solid tumors, NSCLC ...
seekingalpha.com/article/4658550-merus-maybe-building-a-better-bispecific
Paid articlePaid
‘Breakthrough therapy’: a new Chinese drug shows record treatment success against one of the deadliest lung cancers
scmp.com/news/china/science/article/3245435/breakthrough-therapy-new-chinese-drug-shows-record-treatment-success-against-one-deadliest-lung
Bristol Myers to pay $800 million to Chinese drugmaker to develop cancer drug: Bristol Myers Squibb (BMY.N) said on Monday it will pay $800 million up front and ...
reuters.com/business/healthcare-pharmaceuticals/bristol-myers-systimmune-collaborate-cancer-drug-development-2023-12-11/
Merck's lung cancer drug combo fails trial in setback for new therapy class: Merck (MRK.N) said on Thursday a combination treatment testing a new type of ...
reuters.com/business/healthcare-pharmaceuticals/mercks-lung-cancer-drug-combo-fails-meet-trial-goal-2023-12-07/
Allergy medicine may help treat lung cancer, research suggests: Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway ...
medicalxpress.com/news/2023-12-allergy-medicine-lung-cancer.html
AbbVie's $10bn Deal For ImmunoGen: Fundamentals And Rationale Explained: AbbVie Inc.'s $10.1B acquisition of ImmunoGen, Inc. diversifies its oncology pipeline ...
seekingalpha.com/article/4655255-abbvie-10bn-deal-for-immunogen-fundamentals-and-rationale-explained
Paid articlePaid Burning Rock Biotech Limited (BNR) Q3 2023 Earnings Call Transcript: Burning Rock Biotech Limited (NASDAQ:NASDAQ:BNR) Q3 2023 Earnings Call Transcript November ...
seekingalpha.com/article/4655150-burning-rock-biotech-limited-bnr-q3-2023-earnings-call-transcript
Week In Review: BeiGene Signs $1.3 Billion Deal For Preclinical CDK2 Inhibitor From Boston's Ensem
seekingalpha.com/article/4654156-week-in-review-beigene-signs-1-3-billion-deal-for-preclinical-cdk2-inhibitor-from-bostons-ensem
Paid articlePaid
Advances In Lung Cancer Treatment: All You Need To Know: Lung cancer continues to be a significant global health concern, causing more deaths than any other ...
indiatimes.com/health/advances-in-lung-cancer-treatment-621734.html
Pharmacy Board bans use, sale of sexual enhancement drug: Pharmacy and Poisons Board (PPB) cautions the public against the use, sale or distribution of a ...
standardmedia.co.ke/health/health-science/article/2001485843/pharmacy-board-bans-use-sale-of-sexual-enhancement-drug
Who should worry about lung cancer? A doctor explains: The American Cancer Society has just updated their lung cancer screening guidelines in an effort to ...
cnn.com/2023/11/02/health/lung-cancer-prevention-smoking-wellness/
US FDA approves Bristol-Myers' lung cancer drug: The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb's (BMY.N) lung cancer drug that ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-lung-cancer-drug-2023-11-15/
AstraZeneca's Imfinzi plus chemoradiotherapy fail main goal of late stage trial: Drugmaker AstraZeneca (AZN.L) said on Tuesday its cancer drug Imfinzi given ...
reuters.com/business/healthcare-pharmaceuticals/astrazenecas-imfinzi-plus-chemoradiotherapy-fail-main-goal-late-stage-trial-2023-11-14/
Two-drug approach could overcome a common cancer mutation, make treatments more effective
medicalxpress.com/news/2023-11-two-drug-approach-common-cancer-mutation.html
A structural assessment of the area at Megah Rise Mall affected by the ceiling collapse on Saturday (Oct 28) is being done, says developer PPB Properties ... Show more thestartv.com/c/news cutt.ly/TheStar fb.com/TheStarOnline
Structural assessment of ceiling collapse areas underway, says Megah Rise Mall developer
thestar.com.my/news/nation/2023/10/29/structural-assessment-of-ceiling-collapse-areas-underway-says-megah-rise-mall-developer
Merck's Keytruda gets FDA nod for expanded use in lung cancer: The U.S. Food and Drug Administration on Monday approved the expanded use of Merck & Co's (MRK ...
reuters.com/business/healthcare-pharmaceuticals/mercks-keytruda-gets-us-fdas-nod-expanded-use-lung-cancer-2023-10-16/
AstraZeneca shares fall as lung cancer drug trial data abstract disappoints: Shares in AstraZeneca (AZN.L) fell more than 4% on Wednesday after a data abstract ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-shares-fall-abstract-lung-cancer-trial-data-disappoints-2023-10-18/
Lung cancer outcomes found to significantly improve with immunotherapy-based treatment given before and after surgery
medicalxpress.com/news/2023-10-lung-cancer-outcomes-significantly-immunotherapy-based.html
A backyard flower farm helps a young couple cope with cancer: Chad and Stacie Vanags' backyard cutting garden has become a healing sanctuary for the couple and ...
latimes.com/lifestyle/story/2023-10-17/couple-finds-hope-in-flower-farm-after-cancer-diagnosis
Bristol Myers Squibb buys San Diego cancer therapy company for $4.8B: It's unclear what the Bristol Myers Squibb deal with San Diego's Mirati Therapeutics means ...
sandiegouniontribune.com/business/story/2023-10-09/pharmaceutical-giant-buys-san-diego-cancer-therapy-company-mirati-therapeutics-for-4-8b
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics